HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Business (Health)

Set Alert for Business {Health}

Perrigo Expanding Consumer Portfolio After Finding Problems Slowing Growth

"Probably the worst offense" among Perrigo's problems is that before appointing President and CEO Murray Kessler in November, it had three CEOs since 2016, making him the fourth chief executive in three years, says Kessler. Perrigo's move to a self-care focus means "a broader emphasis on the wellness component of health and wellness" and opening its portfolio of products and categories to areas including nutraceuticals, oral care, probiotics, therapeutic skin care products and others.

Commercial OTC Drugs Dietary Supplements

J&J Names New EMEA Chief To Drive Consumer Growth

J&J has turned to long-serving exec Pat Smallcombe to drive growth and market share for its Consumer business in Europe, the Middle East and Africa.
Europe Middle East and Africa Appointments

Italy's Recordati Takes Slice of French OTC Market With Laboratoires Tonipharm

Recordati's new private-equity owners make their first move to strengthen the Italian firm's position in Europe's OTC market by grabbing Paris-based Laboratoires Tonipharm and its leading Ginkor brand.
Deals Health France


Set Alert for Deals {Health}

Latest From Health & Deals

Irish $1.9bn Tax Bill 'Out Of Nowhere' Perplexes Perrigo, Troubles Analysts

Perrigo appeals tax assessment Ireland levied in late December on Rx ingredient royalty rights firm gained when it became incorporated in Dublin but no longer owns, Analysts allowed President and CEO Murray Kessler. benefit of doubt he'll lead Perrigo out of prolonged slump when he joined firm in November after extensive executive experience with tobacco firms and in other consumer goods markets, but they're more circumspect about its chances of prevailing in Irish tax disagreement.

Commercial Policy & Regulation

Burt’s Bees Hopes Third Time’s A Charm For Toothpaste, This One With P&G

Clorox and Procter & Gamble embarked on a strategic licensing partnership to market Burt’s Bees toothpastes, available now in mass retail doors. Billed as simple formulas for adults and kids, with or without fluoride, the line marks the third swing at toothpaste for the iconic natural brand.

Health Deals

Aspen And Mylan Strike A Deal On Australia And New Zealand Portfolio

Mylan has bolstered its presence in key Australasian markets through a portfolio distribution arrangement with Aspen Pharma, which includes an option to buy in March 2019; the South African firm, on the other hand, is continuing to manage its portfolio in the markets, “allowing enhanced operational focus and removing complexity.”
Deals Health
See All


Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

FDA's OTC Naloxone Model Labels Confirmed In CONFER Study

Participants in FDA-commissioned CONFER study were scored on following label instructions for checking whether a potential patient has overdosed and administering a naloxone dose before calling for emergency help as well as on a "composite of cognitive walkthrough" of all those steps. Participants were in four groups: adult users of heroin and prescription opioids; those persons' friends and family members 18 years old and up; and separate groups of volunteers, 15- to 17-year-olds and adults.

Prescription To Otc Switch OTC Drugs

FDA Has Model Drug Facts Labels For OTC Naloxone, Wants Switch Proposals

Development of the model DFLs was a first for agency, reflecting alarm over public health crisis of overdoses from opioid abuse, which reached nearly 48,000 in 2017. The project was "part of our broader commitment to addressing the opioid crisis" and should help sponsors with potential naloxone OTC switch NDAs, says Commissioner Scott Gottlieb.

Prescription To Otc Switch Regulation

Reckitt Begins CEO Search As Kapoor Departs The Company He Reshaped

Reckitt Benckiser's long-serving CEO, Rakesh Kapoor, has unexpectedly announced his intention to retire by the end of the year, with the company immediately kicking off the search for his replacement. Kapoor will be remembered for transforming RB's consumer health business, but also for a number of setbacks under his watch which have impacted results.
Appointments Business Strategies
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Supply issues troubling Bayer Consumer Health

Bayer reported some encouraging third-quarter developments at its Consumer Health business, including the return to shelves of a key OTC brand in China. But there is still more to be done to complete the unit’s turnaround, says global Consumer Health head Heiko Schipper.

Health OTC Drugs

Sanofi’s growth balanced across all geographies

Sanofi enjoyed “balanced growth across all geographies and key categories” at its Consumer Healthcare business in the third quarter, noted group chief executive officer Olivier Brandicourt.

Health OTC Drugs

RB enjoys OTC growth ‘ahead of the market’

Reckitt Benckiser’s (RB’s) OTC business performed “materially ahead of the market” in the third-quarter of 2018, chief executive Rakesh Kapoor informed analysts on the firm’s earnings call.

Health OTC Drugs
See All


Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

J&J CEO Sees Victory Ahead On Talc, Growth From Johnson's Relaunch

JP Morgan analysts had questions and J&J CEO Alex Gorsky and CFO Joseph Wolk had answers about liability suits alleging that use of the Johnson's brand talcum powder has caused mesothelioma or ovarian cancer. On the Johnson's brand outlook following its relaunch as a natural product line, Gorsky says sales were a key driver in the firm's consumer health sales in the 2018 third quarter. China, meanwhile, is a model for growing sales online, he says.
Legal Issues Ingredients

Keystone Labs Court-Ordered To Halt OTC Drug Manufacturing; Cosmetics Not Affected, It Says

Keystone Labs agrees to cease manufacturing OTC drugs following a 2013 FDA warning letter and repeated GMP violations noted during inspections, including failure to investigate sources of contamination. Firm suggests it will continue making cosmetic hair- and skin-care formulas while outsourcing OTC product manufacturing.

Legal Issues Manufacturing

OTC-Only PEG Market Nears After Court Passes On Stopping Rx ANDA Withdrawals

US circuit court rejects petitions from Breckenridge Pharmaceutical, Lannett Co., Nexgen Pharma and Paddock Labs to order FDA to conduct a hearing on their requests to sustain approvals for Rx PEG 3350 generics. FDA's approvals of the Rx ANDAs are set to expire Nov. 2; the agency said the Rx products were rendered unapproved in 2006 when the same formulation became available OTC.

Gastrointestinal Health
See All